Oventus - investment highlights
1. Oventus is driving the most significant change the sleep apnoea market has seen for years
2. Two key product ranges, both of which are set to disrupt a large and growing market:
OzVent Airway Technology oral appliance - currently generating revenue
CPAP machine* connector to 02Vent- in late stage development (replaces face mask)
3. Agreement executed in June 2017 with world's largest dental prosthetics supplier, Modern Dental Group. Oventus and Modern now preparing for Modern to distribute Oventus' range globally through their established channels
4. Obstructive Sleep Apnoea (OSA) is a massive market. US$3.8b globally, growing at a CAGR of 15-20% with only 20% of OSA sufferers in care
5. Strong institutional investor interest and solid balance sheet with $8.6m in cash (as at 30/6/17)
* CPAP machine: continuous positive airway pressure machine.
To view the presentation, please visit:
About Oventus Medical Ltd
Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that has commercialized and brought to market a new sleep treatment platform for the treatment of sleep apnoea and snoring that enhances the treatment outcomes of both oral appliance therapy and CPAP therapy through increased efficacy and greater adherence.
Oventus Medical Ltd